TOI:NASDAQ, The Oncology Institute, Inc.
TOI stock overview
The Oncology Institute, Inc. (TOI:NASDAQ) closed at $5.13 on August 3, 2026,
unchanged on the day.
The stock trades 27.2% below its 52-week high of $7.05
and 121.1% above its 52-week low of $2.32.
The Oncology Institute, Inc. is part of the Finance sector.
Key figures
- Price
- $5.13
- Day change
- 0.00%
- Volume
- 1,212,244
- Average volume
- 1,975,887
- Market cap
- 512M+
- 52-week range
- $2.32 – $7.05
- 50-day average
- $5.23
- 200-day average
- $3.89
Price action over the past year
In 252 trading sessions since October 23, 2025, TOI closed higher on 100 days (40%).
Its best day was November 14, 2025 (+28.90%) and its worst was August 12, 2026 (-17.26%).
The stock moved 10% or more in a single session 8 times.
It opened at least 5% above the previous day's high 2 times.
TOI news
-
Aug 17, 2026:
Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale
-
Aug 17, 2026:
Starling Oncology Launches Starling Nexus, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale
-
Aug 7, 2026:
Oncology Institute Q2 Earnings Call Highlights
-
Aug 6, 2026:
The Oncology Institute, Inc. (STLN) Reports Q2 Loss, Tops Revenue Estimates
-
Aug 6, 2026:
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
-
Aug 5, 2026:
Constellation Software Inc. and Topicus.com Inc. Announce Results for Topicus.com Inc. for the Second Quarter Ended June 30, 2026
-
Aug 5, 2026:
Earnings To Watch: Starling Oncology Inc (STLN) Q2 2026 -- GF Value Sees 44% Downside
-
Aug 3, 2026:
The Oncology Institute Rebrands as Starling Oncology
About The Oncology Institute, Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centers, In-housedispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling.
Similar stocks
Find more stocks like TOI with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.